ARX 1.87% 52.5¢ aroa biosurgery limited

Huge increase in the cost of staff over the past year which...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 964 Posts.
    lightbulb Created with Sketch. 70
    Huge increase in the cost of staff over the past year which prevented positive cashflow. In addition, many of the staff are very well compensated as per the annual report. Considering they are not yet profitable it would be wise to keep a close eye on this significant cost of doing business. Growth in sales staff along with costs for the expansion of production are now complete, therefore increase in sales should positively impact the bottom line?

    I've only recently started looking at ARX. What do long termers see as the positive and negative aspects to this company? Seems they are on the cusp of positive cashflow this year following 15 years of development?
 
watchlist Created with Sketch. Add ARX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.